PuSH - Publikationsserver des Helmholtz Zentrums München

Albert, M.H.* ; Mannert, J.* ; Fleischmann, K.K.* ; Schiemann, M. ; Pagel, P.* ; Schmid, I.* ; Magg, T.*

MiRNome and transcriptome aided pathway analysis in human regulatory T cells.

Genes Immun. 15, 303-312 (2014)
Verlagsversion DOI PMC
Free by publisher
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Owing to their manifold immune regulatory functions, regulatory T cells (Treg) have received tremendous interest as targets for therapeutic intervention of diverse immunological pathologies or cancer. Directed manipulation of Treg will only be achievable with extensive knowledge about the intrinsic programs that define their regulatory function. We simultaneously analyzed miR and mRNA transcript levels in resting and activated human Treg cells in comparison with non-regulatory conventional T cells (Tcon). Based on experimentally validated miR-target information, both transcript levels were integrated into a comprehensive pathway analysis. This strategy revealed characteristic signal transduction pathways involved in Treg biology such as T-cell receptor-, Toll-like receptor-, transforming growth factor-β-, JAK/STAT (Janus kinase/signal transducers and activators of transcription)- and mammalian target of rapamycin signaling, and allowed for the prediction of specific pathway activities on the basis of miR and mRNA transcript levels in a probabilistic manner. These data encourage new concepts for targeted control of Treg cell effector functions.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Foxp3 Target Genes; Nf-kappa-b; Immune-responses; Th1 Responses; Expression; Microrna; Induction; Differentiation; Smad3; Lists
ISSN (print) / ISBN 1466-4879
e-ISSN 1476-5470
Zeitschrift Genes and Immunity
Quellenangaben Band: 15, Heft: 5, Seiten: 303-312 Artikelnummer: , Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Molecular Immunology (IMI)